Dr. DeMichele is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 South, Perelman Center for Advanced Medicine, University of Pennsylvania
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-349-5730Fax+1 215-615-3349- Is this information wrong?
Education & Training
- University of Pennsylvania, School of MedicineM.S.C.E., Clinical Epidemiology, 2001
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1992 - 1994
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1991 - 1992
- Washington University in St. Louis School of MedicineClass of 1991
- Brown UniversityB.A., Biochemistry, 1983 - 1987
Certifications & Licensure
- PA State Medical License 1991 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Advancing Innovation Award (DeMichele, ISPY/TRANSCEND Team Team Co-Investigator) caBIG®, 2010
- Alavi Award for Excellence in Cancer Research Abramson Cancer Center, 2007
- Join now to see all
Clinical Trials
- Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy Start of enrollment: 2006 Jun 01
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer Start of enrollment: 2007 May 01
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Horm...Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara Abdou, Elizabeth C Riley, ...> ;Journal of Clinical Oncology. 2024 Mar 21
- Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.Lawrence-Paul, M., Pan, T., Pant, D., Shih, N., Chen, Y., Belka, G., Feldman, M., DeMichele, A., Chodosh, L.> ;Genome Medicine. 2024 Feb 6
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Smith, K., Zhao, F., Mayer, I., Tevaarwerk, A., Garcia, S., Arteaga, C., Symmans, W., Park, B., Burnette, B., Makower, D., Block, M., Morley, K., Jani, C., Mescher, C....> ;Cancer. 2024 Jan 18
- Join now to see all
Journal Articles
- Distinct Microbial Signatures Associated with Different Breast Cancer TypesAngela M. DeMichele, Michael D. Feldman, Frontiers in Neurology
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast CancerAustin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research
- A randomized trial of electro-accupuncture for arthralgia related to aromatase inhibitor useMao JJ, Xie SX, Farrar JT, Stricker CT, Bowman MA, Bruner D, DeMichele A, European Journal of Cancer, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Phase II Trial of the CDK 4/6 Inhibitor PD0332991 in Advanced Breast Cancer.DeMichele A, Clark A, Tan KS, Heitjan D, Randolph S, Christensen J, Gallagher M, Lal P, Feldman M, Zhang P, Domchek S, Gogineni K, Keefe S, Rosen M, Fox K, O'Dwyer P, American Society of Clinical Oncology, 1/1/2013
Lectures
- "San Antonio Update 2013"Morristown, NJ - 1/1/2014
- "Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL"Philadelphia, PA - 1/1/2014
- "Palbociclib in Breast Cancer"Washington, DC - 1/1/2014
- Join now to see all
Press Mentions
- Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO AwardsMay 23rd, 2023
- Irish Oncologist to Be Honored at ASCOMay 16th, 2023
- SABCS 2022: Panelists Focus on Methods to Overcome High Obstacles in Breast Most Cancers AdministrationDecember 19th, 2022
- Join now to see all
Grant Support
- Molecular &Genetic Determinants Of Outcome In Breast CancerNational Cancer Institute2007–2008
- Molecular &Genetic Determinants Of Outcome In Breast CANational Cancer Institute2004–2006
- Age, Cell Cycle Markers And Breast Cancer OutcomesNational Cancer Institute1999–2004
Professional Memberships
- Member
- Member
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: